NewsRx

Search our medical news database

Haemonetics Corporation

Haemonetics Announces Change to Board of Directors

Published in Hospital Business Week, April 26th, 2009

Haemonetics Corporation (NYSE:HAE) announced that Richard Meelia has retired from its Board of Directors effective April 2, 2009. Mr. Meelia is Chairman, President and CEO of Covidien Ltd., a global healthcare products company. He is retiring from Haemonetics' Board in order to spend more professional time on Covidien's operations.

Brad Nutter, Chairman of Haemonetics' Board of Directors, said, "We appreciate Rich's leadership and guidance during his four-year tenure with Haemonetics. His breadth of experience in healthcare has been a strong complement to the Board, particularly as we've made key strategic decisions and transformed the Company from a niche medical...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook